Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded revision label v3.4.2 and removed v3.4.1 from the history log.SummaryDifference0.1%

- Check18 days agoChange DetectedSanofi is now listed as sponsor/collaborators; Provention Bio is removed. The page history now includes a Study Status section.SummaryDifference0.8%

- Check19 days agoChange DetectedSponsor/Collaborators now lists Sanofi instead of Provention Bio, a Sanofi Company. The Study Status was updated as part of revision v3.4.1 (dated 2026-01-30).SummaryDifference0.8%

- Check41 days agoChange DetectedNew revision entry v3.3.4 was added to the study record versions, and revision v3.3.3 was removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.3 was added to the history, and the footer link to HHS Vulnerability Disclosure was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page. This is a non-functional UI/version-label change with no impact on trial data or historical records; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.